最終更新日：2025/12/06
The clinical trial showed that gilteritinib significantly improved survival in patients with relapsed acute myeloid leukemia.
正解を見る
The clinical trial showed that gilteritinib significantly improved survival in patients with relapsed acute myeloid leukemia.
音声機能が動作しない場合はこちらをご確認ください
編集履歴（0）
